
北美精密诊断市场预测至 2028 年 – COVID-19 影响和区域分析 – 按类型(基因测试、深奥测试等)、应用(肿瘤学、心脏病学、呼吸系统疾病、免疫学等)和最终用户(临床实验室、医院、家庭护理等)
No. of Pages: 136 | Report Code: BMIRE00026146 | Category: Life Sciences
No. of Pages: 136 | Report Code: BMIRE00026146 | Category: Life Sciences
北美精准诊断市场预计将从2022年的33,625.95百万美元增长到71,825.04美元到 2028 年将达到 100 万。预计 2022 年至 2028 年复合年增长率为 13.5%。
精准医疗理念正在大力应用于罕见疾病的治疗。尽管它在肿瘤学中更为普遍,但它正在逐渐传播到其他专业。癌症患病率的上升和罕见神经系统疾病发病率的增加增加了对精准医疗的需求,从而推动了精准诊断市场的增长。此外,肿瘤学和其他疾病对治疗程序的需求不断增长,导致治疗程序的采用激增。基因测试在许多医学领域都很有用,因为它可以识别 DNA 中的突变或变异。例如,基因检测可提供有关患癌症风险的信息并诊断遗传疾病,例如脆性 X 综合征或亨廷顿舞蹈症。
根据癌症类型,基因组癌症检测有助于制定更加个性化的癌症治疗和护理计划,帮助患者和医生更好地了解诊断并揭示特定的癌症驱动因素,市场参与者鼓励从诊断一开始就进行基因组癌症检测,以便精准医疗可以在治疗过程的早期进行。因此,早期诊断有助于促进疾病的早期和最佳管理。
此外,生物制药公司之间的战略合作越来越多根据特定患者的特殊需求开发针对特定患者群体的药物正在增加临床试验的数量。提供有效治疗程序和服务的需求也促进了临床试验的兴起。例如,Personal Genome Diagnostics Inc. 和麻省总医院在 2021 年合作推进有效治疗服务的开发。2022 年 4 月,精准癌症联盟 (PCC) 成立,这是制药公司的一个新合作项目,其共同愿景是提供对所有癌症患者进行全面检测。该联盟旨在通过全面的基因组测试增加患者获得精确诊断的机会。上述因素正在大力推动精准诊断市场的发展。
< p>
北美精密诊断市场细分
北美精准诊断市场按类型、应用、最终用户和国家/地区进行细分。根据类型,市场分为基因测试、深奥测试等。 2022 年,基因测试领域在市场中占据主导地位。
根据应用,市场细分为肿瘤学、心脏病学、免疫学、呼吸系统疾病等。 2022 年,肿瘤学领域在市场中占据主导地位。根据最终用户,市场分为医院、临床实验室、家庭护理等。 2022 年,临床实验室领域在市场中占据主导地位。
根据国家/地区,市场< /span>分为美国、加拿大和墨西哥。此外,美国将在 2022 年主导市场。
一些主要参与者主导北美精准诊断市场 是雅培;拜耳公司;皇家飞利浦公司; Lantheus 医学影像公司;诺华公司;凯杰;奎斯特诊断公司;赛诺菲;西门子医疗股份公司;和瑞士精密诊断有限公司。
Strategic insights for North America Precision Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 33,625.95 Million |
Market Size by 2028 | US$ 71,825.04 Million |
Global CAGR (2022 - 2028) | 13.5% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Precision Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Precision Diagnostics Market is valued at US$ 33,625.95 Million in 2022, it is projected to reach US$ 71,825.04 Million by 2028.
As per our report North America Precision Diagnostics Market, the market size is valued at US$ 33,625.95 Million in 2022, projecting it to reach US$ 71,825.04 Million by 2028. This translates to a CAGR of approximately 13.5% during the forecast period.
The North America Precision Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Precision Diagnostics Market report:
The North America Precision Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Precision Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Precision Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.